Health
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
![Medications on a pharmacy shelf.]()
Drug Prices
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Affordability
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
![People stand at a podium with signs of support for SB 175.]()
Drug Prices
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Affordability
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
![Getty Images 149262153]()
Drug Prices
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Affordability
Complex Care
New Resources Enable Investigators to Expand Research into Dual-Eligible Individuals
COVID-19’s Toll Underscores Need to Address Health and Social Needs of Dual-Eligible Individuals
![Getty Images 1294797563]()
Complex Care
COVID-19’s Toll Underscores Need to Address Health and Social Needs of Dual-Eligible Individuals
Protecting Patients From the Cost of Surprise Billing is Not Finished
![Hospital]()
Commercial Sector Prices
Protecting Patients From the Cost of Surprise Billing is Not Finished
Home and Community-Based Services: Just One Piece of the Puzzle
![Getty Images 1316466784]()
Complex Care
Home and Community-Based Services: Just One Piece of the Puzzle
FDA's Pfizer Vaccine Approval is Proof that Public-Private Partnerships Work
![COVID vaccine]()
Drug Prices
FDA’s Pfizer Vaccine Approval is Proof that Public-Private Partnerships Work
Complex Care Opens the Lines for Consumer Voices
![Complex Care Integration]()
Complex Care
Complex Care Opens the Lines for Consumer Voices
Any Public Option Design Must Lower Health Care Costs
![A hospital room]()
Commercial Sector Prices
Any Public Option Design Must Lower Health Care Costs
5 Things to Watch for in the Medicare Trustees’ Report
![Medicare]()
Medicare Sustainability
5 Things to Watch for in the Medicare Trustees’ Report
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
![Prescription Drug Prices]()
Drug Prices
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
More Research is Essential to Improve Care for Dual-Eligible Beneficiaries
![Shutterstock 1639731799]()
Complex Care
More Research is Essential to Improve Care for Dual-Eligible Beneficiaries
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
![Health care prices]()
Commercial Sector Prices
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
Video Series: Health Care Prices
As Government Eyes Health Equity, Improving Care for Dual-Eligible Individuals Must Be a Key Focus
![Dual Eligible Header]()
Complex Care
As Government Eyes Health Equity, Improving Care for Dual-Eligible Individuals Must Be a Key Focus
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
![Prescription bill bottles]()
Drug Prices
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
'We Have a Problem': New Alzheimer’s Treatment Reflects Dysfunctional U.S. Drug Market
![Aducanumab Alzheimer's drug]()
Drug Prices
‘We Have a Problem’: New Alzheimer’s Treatment Reflects Dysfunctional U.S. Drug Market
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
![A hospital room]()
Commercial Sector Prices
Part 2: In No Surprises Act, Arbitration Design Is Key to Realizing Expected Savings
Part 1: Fulfilling the Promises of the Surprise Billing Ban
![Hospital bill]()
Commercial Sector Prices
Part 1: Fulfilling the Promises of the Surprise Billing Ban
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
![An injection of insulin]()
Drug Prices
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Q&A
Complex Care
More Robust Data, Measurement Systems are Needed to Understand Impacts of Flexible Benefits in Medicare Program
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
